Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bode

Showing results (541-550 of 548) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 548 results.
Circulation|March 17, 2004
CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralizationN van Royen, M Voskuil, I Hoefer, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2000
Effects of ENU dosage on mouse strainsM J Justice, D A Carpenter, J Favor, et al.
Biochemical Pharmacology|June 28, 1996
In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitorsD G Sawutz, D C Bode, G M Briggs, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Alcohol and retinoidsD W Crabb, J Pinairs, R Hasanadka, et al.
Circulation|October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III TrialE J Topol, E M Ohman, P W Armstrong, et al.
Thrombosis and Haemostasis|March 22, 2014
Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in miceF Willecke, S Tiwari, B Rupprecht, et al.
Purinergic Signalling|July 20, 2021
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profileJ Merz, A Nettesheim, S von Garlen, et al.
West African Journal of Medicine|October 31, 2023
Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in NigeriaO O Aina, A A Busari, D A Oladele, et al.
Pageof 55

Showing results (541-550 of 548) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 548 results.
Circulation|March 17, 2004
CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralizationN van Royen, M Voskuil, I Hoefer, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2000
Effects of ENU dosage on mouse strainsM J Justice, D A Carpenter, J Favor, et al.
Biochemical Pharmacology|June 28, 1996
In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitorsD G Sawutz, D C Bode, G M Briggs, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Alcohol and retinoidsD W Crabb, J Pinairs, R Hasanadka, et al.
Circulation|October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III TrialE J Topol, E M Ohman, P W Armstrong, et al.
Thrombosis and Haemostasis|March 22, 2014
Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in miceF Willecke, S Tiwari, B Rupprecht, et al.
Purinergic Signalling|July 20, 2021
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profileJ Merz, A Nettesheim, S von Garlen, et al.
West African Journal of Medicine|October 31, 2023
Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in NigeriaO O Aina, A A Busari, D A Oladele, et al.
Pageof 55